You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 8, August 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals?

M. E. Strauss and J. Brandt
Department of Psychiatry, Johns Hopkins University, Baltimore, Md.

It has recently been reported that persons at risk for Huntington's disease who test positive for the linked restriction fragment length polymorphism on chromosome 4 display neuropsychologic impairments when compared with at-risk subjects who test negative for this marker. We have studied a substantially larger series of at-risk subjects who have been thoroughly screened for the absence of neurologic or psychiatric features of Huntington's disease and have undergone predictive DNA testing. No evidence of cognitive or emotional differences between marker-positive and marker-negative individuals was found. Consideration of the designs and findings of the two studies indicates that it is premature to conclude that there are neuropsychologic impairments in Huntington's disease that precede the clinical onset of the illness.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:874-880.
ABSTRACT | FULL TEXT  

Clinical Characteristics of Childhood-Onset (Juvenile) Huntington Disease: Report of 12 Patients and Review of the Literature
Gonzalez-Alegre and Afifi
J Child Neurol 2006;21:223-229.
ABSTRACT  

Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease
Van Raamsdonk et al.
J. Neurosci. 2005;25:4169-4180.
ABSTRACT | FULL TEXT  

Cognitive and Motor Functioning in Gene Carriers for Huntington's Disease: A Baseline Study
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:7-16.
ABSTRACT | FULL TEXT  

Behavioural complaints in participants who underwent predictive testing for Huntington's disease
Witjes-Ane et al.
J. Med. Genet. 2002;39:857-862.
FULL TEXT  

Clinical markers of early disease in persons near onset of Huntington's disease
Paulsen et al.
Neurology 2001;57:658-662.
ABSTRACT | FULL TEXT  

Effects of Depression on Working Memory in Presymptomatic Huntington's Disease
Nehl et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:342-346.
ABSTRACT | FULL TEXT  

Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood et al.
Arch Neurol 2001;58:273-278.
ABSTRACT | FULL TEXT  

Longitudinal Cognitive and Motor Changes Among Presymptomatic Huntington Disease Gene Carriers
Kirkwood et al.
Arch Neurol 1999;56:563-568.
ABSTRACT | FULL TEXT  

Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers
Hahn-Barma et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:172-177.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.